High Dose Vitamin C has a role in cancer treatment.
Frontiers | Therapeutic Use of Vitamin C in Cancer: Physiological Considerations
UI researchers discover vitamin C may offer new treatment option for multiple myeloma | Office of the Vice President for Research | The University of Iowa
Vitamin C Treatment for Cancer in India | Vitamin C Therapy | Mirakle Wellness Clinic
Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations
Intravenous High-Dose Vitamin C in Cancer Therapy - NCI
Combining vitamin C with antibiotics destroys cancer stem cells
The Vitamin Myth: Why We Think We Need Supplements - The Atlantic
High-dose vitamin C makes cancer treatment more effective, trial shows
Frontiers | Therapeutic Use of Vitamin C in Cancer: Physiological Considerations
Vitamin C Against Cancer | IntechOpen
Vitamin C as a cancer treatment: the evidence so far - Cancer Research UK - Cancer news
High Dose Vitamin C Enhances Cancer Immune Drugs - LEMMO
Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
New Study PROVES Vitamin C fights CANCER! - YouTube
Mounting research on vitamin C's role in cancer and infection may change treatment methods
Killing cancer with vitamin C: Hype or hope?
Revisiting vitamin C and cancer | Science
Metabolomic alterations in human cancer cells by vitamin C-induced oxidative stress | Scientific Reports
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
Can Intravenous Vitamin C Cure Cancer? | Loudoun Holistic Health Partners
How Does Vitamin C Work To Fight Cancer? — San Francisco Natural Medicine
Little clinical evidence supports the use of high-dose intravenous vitamin C to treat cancer - Health Feedback
Intravenously administered vitamin C as cancer therapy: three cases | CMAJ
High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial | PLOS ONE
